Resistance mechanisms of multiresistant Pseudomonas aeruginosa strains from Germany and correlation with hypermutation
- PMID: 17876002
- PMCID: PMC2151423
- DOI: 10.1128/AAC.00148-07
Resistance mechanisms of multiresistant Pseudomonas aeruginosa strains from Germany and correlation with hypermutation
Abstract
In this study, we analyzed the mechanisms of multiresistance for 22 clinical multiresistant and clonally different Pseudomonas aeruginosa strains from Germany. Twelve and 10 strains originated from cystic fibrosis (CF) and non-CF patients, respectively. Overproduction of the efflux systems MexAB-OprM, MexCD-OprJ, MexEF-OprN, and MexXY-OprM was studied. Furthermore, loss of OprD, alterations in type II topoisomerases, AmpC overproduction, and the presence of 25 acquired resistance determinants were investigated. The presence of a hypermutation phenotype was also taken into account. Besides modifications in GyrA (91%), the most frequent mechanisms of resistance were MexXY-OprM overproduction (82%), OprD loss (82%), and AmpC overproduction (73%). Clear differences between strains from CF and non-CF patients were found: numerous genes coding for aminoglycoside-modifying enzymes and located, partially in combination with beta-lactamase genes, in class 1 integrons were found only in strains from non-CF patients. Furthermore, multiple modifications in type II topoisomerases conferring high quinolone resistance levels and overexpression of MexAB-OprM were exclusively detected in multiresistant strains from non-CF patients. Correlations of the detected phenotypes and resistance mechanisms revealed a great impact of efflux pump overproduction on multiresistance in P. aeruginosa. Confirming previous studies, we found that additional, unknown chromosomally mediated resistance mechanisms remain to be determined. In our study, 11 out of 12 strains and 3 out of 10 strains from CF patients and non-CF patients, respectively, were hypermutable. This extremely high proportion of mutator strains should be taken into consideration for the treatment of multiresistant P. aeruginosa.
Figures

Similar articles
-
Role of efflux pumps: MexAB-OprM and MexXY(-OprA), AmpC cephalosporinase and OprD porin in non-metallo-β-lactamase producing Pseudomonas aeruginosa isolated from cystic fibrosis and burn patients.Infect Genet Evol. 2014 Jun;24:187-92. doi: 10.1016/j.meegid.2014.03.018. Epub 2014 Mar 30. Infect Genet Evol. 2014. PMID: 24694825
-
Loss of activity of ceftazidime-avibactam due to MexAB-OprM efflux and overproduction of AmpC cephalosporinase in Pseudomonas aeruginosa isolated from patients suffering from cystic fibrosis.Int J Antimicrob Agents. 2018 Nov;52(5):697-701. doi: 10.1016/j.ijantimicag.2018.07.027. Epub 2018 Aug 3. Int J Antimicrob Agents. 2018. PMID: 30081137
-
The frequency of AmpC overproduction, OprD downregulation and OprM efflux pump expression in Pseudomonas aeruginosa: A comprehensive meta-analysis.J Glob Antimicrob Resist. 2024 Dec;39:159-169. doi: 10.1016/j.jgar.2024.08.014. Epub 2024 Sep 18. J Glob Antimicrob Resist. 2024. PMID: 39303871
-
Mutation-driven β-lactam resistance mechanisms among contemporary ceftazidime-nonsusceptible Pseudomonas aeruginosa isolates from U.S. hospitals.Antimicrob Agents Chemother. 2014 Nov;58(11):6844-50. doi: 10.1128/AAC.03681-14. Epub 2014 Sep 2. Antimicrob Agents Chemother. 2014. PMID: 25182652 Free PMC article.
-
[Interpretive reading of the non-fermenting gram-negative bacilli antibiogram].Enferm Infecc Microbiol Clin. 2010 Dec;28(10):726-36. doi: 10.1016/j.eimc.2010.05.001. Epub 2010 Jun 26. Enferm Infecc Microbiol Clin. 2010. PMID: 20579775 Review. Spanish.
Cited by
-
Antimicrobial Activity of Fosfomycin-Tobramycin Combination against Pseudomonas aeruginosa Isolates Assessed by Time-Kill Assays and Mutant Prevention Concentrations.Antimicrob Agents Chemother. 2015 Oct;59(10):6039-45. doi: 10.1128/AAC.00822-15. Epub 2015 Jul 20. Antimicrob Agents Chemother. 2015. PMID: 26195514 Free PMC article.
-
Changes in the expression of mexB, mexY, and oprD in clinical Pseudomonas aeruginosa isolates.Proc Jpn Acad Ser B Phys Biol Sci. 2024;100(1):57-67. doi: 10.2183/pjab.100.006. Proc Jpn Acad Ser B Phys Biol Sci. 2024. PMID: 38199247 Free PMC article.
-
MexXY multidrug efflux system of Pseudomonas aeruginosa.Front Microbiol. 2012 Nov 28;3:408. doi: 10.3389/fmicb.2012.00408. eCollection 2012. Front Microbiol. 2012. PMID: 23233851 Free PMC article.
-
Determinants of intrinsic aminoglycoside resistance in Pseudomonas aeruginosa.Antimicrob Agents Chemother. 2012 Nov;56(11):5591-602. doi: 10.1128/AAC.01446-12. Epub 2012 Aug 20. Antimicrob Agents Chemother. 2012. PMID: 22908149 Free PMC article.
-
Resistome Signature and Antibiotic Resistance Mechanisms in Rhizospheric Soil Bacteriomes of Mecca Region, Saudi Arabia: Insights into Impact on Human Health.Life (Basel). 2024 Jul 24;14(8):928. doi: 10.3390/life14080928. Life (Basel). 2024. PMID: 39202671 Free PMC article.
References
-
- Bonomo, R. A., and D. Szabo. 2006. Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa. Clin. Infect. Dis. 43:S49-S56. - PubMed
-
- European Committee for Antimicrobial Susceptibility Testing (EUCAST). 2003. Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by broth dilution. Clin. Microbiol. Infect. Dis. 9:1-7. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources